MedPath

Blood Flow Restricted Resistance Training in Peripheral Arterial Disease

Not Applicable
Completed
Conditions
Peripheral Arterial Disease
Interventions
Other: Blood flow restricted resistance exercise (BFR)
Other: Resistance exercise without blood flow restricted (NON-BFR)
Registration Number
NCT04890275
Lead Sponsor
Sheffield Hallam University
Brief Summary

A randomised controlled trial evaluating the feasibility and acceptability of a 12 week lower body blood flow restricted resistance exercise programme for people with peripheral arterial disease.

Detailed Description

The primary aim of this study is to determine the feasibility of 12 weeks of lower body resistance exercise performed with blood flow restriction (BFR) in people with peripheral arterial disease.

Resistance exercise with BFR involves placing inflatable cuffs proximal to the exercise limbs in order to manipulate blood flow and enhance the training response.

Secondary aim of this study is to evaluate changes in ABPI, muscle size, strength and physical function at mid-and post- intervention.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Men and women with PAD 6 months post diagnosis.
  • Ankle-brachial pressure index <0.9.
  • People physically able to perform leg press and leg extension resistance exercise.
Exclusion Criteria
  • Ankle-brachial pressure index >0.89.
  • People unable to visit the laboratory twice weekly for exercise sessions.
  • People unable to do leg press and leg extension exercise.
  • People whose walking is limited by a non-PAD condition.
  • People with PAD with critical limb ischemia (including symptoms of pain at rest and skin ulcers).
  • People with Dementia.
  • People who have had major surgery or myocardial infarction within the past 6 months.
  • Previous stroke.
  • Previous thrombosis.
  • People who have major surgery scheduled during the intervention period.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
BFRBlood flow restricted resistance exercise (BFR)Participants will participate in a supervised low load lower body blood flow restriction resistance exercise program twice a week for 12 weeks
NON-BFRResistance exercise without blood flow restricted (NON-BFR)Participants will participate in a supervised low load lower resistance exercise program twice a week for 12 weeks (matched training volume as experimental arm but without BFR)
Primary Outcome Measures
NameTimeMethod
Recruitment Rates3 months

Defined as rate of invited participants who are eligible and consenting.

Retention Rates3 months

Retention rates will be established as discontinuation with the exercise intervention and absence from the assessment sessions.

Acceptability of allocation3 months

will be assessed by attrition rates, comparing participant withdrawal between experimental and control groups and reasons for dropout where appropriate.

Acceptability of the exercise study3 months

Will be evaluated by participants feedback via one-to-one semi-structured interviews.

Completion Rates3 months

Completion is determined by participants that attend baseline testing and post exercise intervention testing.

Secondary Outcome Measures
NameTimeMethod
Change in walk ability3 months

Measured via the 6-minute walk test

Change in PAD severity3 months

ankle-brachial pressure index

Change in muscle size3 months

Size of vastus lateralis measured via ultrasound

Change in strength3 months

Unilateral isometric maximal voluntary contraction

Change in physical function3 months

Measured via timed up-and-go test

Trial Locations

Locations (1)

Sheffield Hallam University

🇬🇧

Sheffield, South Yorkshire, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath